Procter & Gamble Hygiene and Health Care Ltd

The company maintains a strong liquidity position, with a current ratio of 1.21 and cash and equivalents amounting to INR 4.1 billion, which supports its short-term obligations. The debt-to-equity ratio is 0.0, indicating no long-term debt, and the capital structure is primarily equity-based. The operating cash flow of INR 5.93 billion further reinforces the company's ability to fund operations and capital expenditures without external financing.

In terms of profitability, the company reports a return on equity (ROE) of 86.38% and a return on assets (ROA) of 36.28%, both of which are significantly higher than the typical benchmarks for the Personal Products industry. These metrics suggest that the company is effectively utilizing its equity and assets to generate returns.

The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of segmental and geographic detail limits the ability to assess exposure to regional or product-specific risks.

The company's growth trajectory is not explicitly outlined in the available data, but the strong operating cash flow and high ROE suggest a stable and profitable business model. Analysts have provided a mean price target of INR 11,967 and a median price target of INR 12,650, indicating a generally positive outlook.

The risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's capital structure is free of long-term debt, and the absence of dilution risk suggests that the ownership structure is stable.

Recent events, including filings and transcripts, are not detailed in the available data. However, the company's strong financial performance and positive analyst sentiment suggest that it is well-positioned in the market.